Recently, Fusen Pharmaceutical's product Flunarizine Hydrochloride Capsules received the Notice of Approval of Supplementary Application for Drugs (Notice No. 2023B01068) issued by the State Drug Administration, announcing that the product successfully passed the evaluation of consistency of quality and efficacy of generic drugs, marking that the company's series of products have achieved phased results in the evaluation of consistency of generic drugs.

Basic information

Drug name: Flunarizine Hydrochloride Capsules

Dosage form: capsule

Specification: 5mg (calculated as C26H26F2N2)

Registration classification: Chemical drugs

Applicant: Henan Fushen Pharmaceutical Co., Ltd

Original approval number: Guoyao Zhunzi H10900040

Approval conclusion: This product has been evaluated for consistency in quality and efficacy of generic drugs

According to the instructions of Flunarizine Hydrochloride Capsules, Flunarizine Hydrochloride is a calcium channel blocker. It can prevent cell damage caused by pathological intracellular calcium overload caused by ischemia and other reasons. This product has the following advantages: ① it can relieve vasospasm, and has a lasting inhibitory effect on the persistent vasospasm caused by vasoconstrictors, especially on the basilar artery and internal carotid artery, and its effect is 15 times stronger than that of cerebropyrazine; ② Vestibular inhibition can increase the blood flow of cochlear arterioles and improve the circulation of vestibular organs; ③ Anti epileptic effect: this product can block pathological calcium overload of nerve cells to prevent paroxysmal depolarization and cell discharge, thus avoiding seizures; ④ Protect the myocardium and significantly reduce ischemic myocardial damage; ⑤ Flunarizine can also improve renal function, and can be used for chronic renal failure; In addition, this product also has anti histamine effects.

▲ For medical professionals' reference only

Fusen Pharmaceutical is the first enterprise in China to imitate Flunarizine Hydrochloride Capsules, and the product quality is stable. This consistency evaluation means that the Flunarizine Hydrochloride Capsules of Fusen Pharmaceutical is a drug with the same quality and efficacy as the original drug, and can be replaced with the original drug in clinical practice, which has accumulated valuable experience for the follow-up product related work. In addition, generic drugs have lower prices than original research drugs, which can effectively improve patients' medical experience, improve their quality of life, increase their willingness to seek medical treatment, and help more patients obtain affordable treatment. In the future, Fusen Pharmaceutical will continue to uphold the concept of craftsmanship, quality, and health as blessings, and better safeguard the health of the public.